COMPARISON OF TRANSDERMAL AND SUBCUTANEOUS TERIPARATIDE EFFECTS ON MARKERS OF BONE TURNOVER AND SAFETY IN POSTMENOPAUSAL WOMEN

被引：0
|
作者：
Kenan, Y. [1 ]
Kochba, E. [1 ]
Shahar, M. [1 ]
Gadasi, H. [1 ]
Levin, G. [1 ]
Foldes, A. J. [2 ]
Ish-Shalom, S. [3 ]
Matsumoto, T. [4 ]
Lindsay, R. [5 ]
Christiansen, C. [7 ]
Neer, R. [6 ]
机构：
[1] TransPharma Med Ltd, Lod, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Rambam Hlth Care Ctr, Metabol Bone Dis Unit, Haifa, Israel
[4] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan
[5] Helen Hayes Hosp, W Haverstraw, NY USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Nord Biosci, Herlev, Denmark
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [41] BIOCHEMICAL MARKERS OF BONE TURNOVER AND BONE-DENSITY IN HEALTHY POSTMENOPAUSAL WOMEN
    CAMPUSANO, C
    LOPEZ, JM
    GONZALEZ, G
    ROJAS, A
    ARTEAGA, E
    RODRIGUEZ, J
    REVISTA MEDICA DE CHILE, 1993, 121 (09) : 1000 - 1005
  • [42] Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
    Chavassieux, Pascale
    Portero-Muzy, Nathalie
    Roux, Jean-Paul
    Garnero, Patrick
    Chapurlat, Roland
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (12): : 4662 - 4668
  • [43] Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment
    Olmos, Jose M.
    Hernandez, Jose L.
    Martinez, Josefina
    Castillo, Jesus
    Valero, Carmen
    Perez Pajares, Isabel
    Nan, Daniel
    Gonzalez-Macias, Jesus
    MATURITAS, 2010, 65 (04) : 396 - 402
  • [44] BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN HYPERTENSIVE POSTMENOPAUSAL WOMEN ON TREATMENT
    Olmos, J. M.
    Hernandez, J. L.
    Martinez, J.
    Castillo, J.
    Valero, C.
    Perez Pajares, I.
    Nan, D.
    Gonzalez Macias, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 259 - 259
  • [45] Cytokines and biochemical markers of bone turnover in the prediction of bone loss in postmenopausal women
    Rogers, A
    Hannon, R
    Eastell, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : P262 - P262
  • [46] ARZOXIFENE VERSUS RALOXIFENE: 12-MONTH EFFECTS ON BONE MINERAL DENSITY, BONE TURNOVER MARKERS, AND SAFETY PARAMETERS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Zanchetta, J. R.
    Palacios, S.
    Cox, D. A.
    Stock, J. L.
    Alam, J.
    Dowsett, S. A.
    Kendler, D. L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 166 - 167
  • [47] ARZOXIFENE VERSUS RALOXIFENE: 12-MONTH EFFECTS ON BONE MINERAL DENSITY, BONE TURNOVER MARKERS, AND SAFETY PARAMETERS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Zanchetta, J.
    Palacios, S.
    Cox, D.
    Stock, J.
    Dowsett, S.
    Kendler, D.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 14 - 15
  • [48] Arzoxifene versus raloxifene: 12-month effects on bone mineral density, bone turnover markers, and safety parameters in postmenopausal women with osteoporosis
    Kendler, D.
    Palacios, S.
    Cox, D.
    Stock, J.
    Dowsett, S.
    Zanchetta, J.
    BONE, 2009, 44 (02) : S226 - S227
  • [49] Differential effects of teriparatide and alendronate on bone parameters in postmenopausal women with osteoporosis
    McClung, MR
    Martin, JS
    Meunier, PJ
    Miller, PD
    Haddock, L
    Bandeira, F
    Szejnfled, V
    Donley, DW
    Eriksen, EF
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S5 - S5
  • [50] Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass
    Downs, R. W., Jr.
    Moffett, A. M.
    Ghosh, A.
    Cox, D. A.
    Dowsett, S. A.
    Harper, K.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (07) : 1215 - 1226
12345